Brufen 200 mg (Ibuprofen)

Product Overview

Brufen 200 mg is a clinically proven non‑steroidal anti‑inflammatory drug (NSAID) formulated to provide rapid relief from fever and mild to moderate pain. Manufactured by Abbott India Pvt. Ltd., this product is supplied in a convenient strip containing fifteen tablets, each delivering a precise 200 mg dose of ibuprofen. The medication is indicated for the symptomatic treatment of fever associated with infections, inflammatory conditions, and post‑operative discomfort. Packaged in a child‑resistant, foil‑lined strip, Brufen 200 mg ensures stability and potency throughout its shelf life, which is further supported by a delivery window of six to fifteen days for domestic orders. The strip is sealed with a tamper‑evident foil to preserve integrity, and each tablet is scored for easy splitting if a lower dose is required, though splitting is not recommended without medical guidance.

What is Brufen 200 mg

Brufen 200 mg belongs to the class of propionic acid derivatives and is chemically identified as (±)-2‑(4‑isobutylphenyl)propionic acid. As an NSAID, it functions by selectively inhibiting the cyclooxygenase enzymes COX‑1 and COX‑2, which are responsible for the synthesis of prostaglandins that mediate inflammation, pain, and fever. The inhibition of these enzymes results in a measurable reduction in the hypothalamic set‑point for temperature regulation, thereby lowering elevated body temperature. Additionally, the analgesic effect arises from decreased synthesis of prostaglandin‑mediated nociceptive mediators in peripheral tissues, making Brufen 200 mg effective for both fever reduction and pain alleviation. Pharmacokinetic studies have demonstrated that the drug exhibits linear absorption and a half‑life of approximately two to three hours, allowing for predictable plasma concentrations throughout the dosing interval.

Uses and Benefits

The therapeutic utility of Brufen 200 mg extends across several clinical scenarios where fever or mild to moderate pain necessitates prompt intervention. Clinicians commonly prescribe this formulation for the management of febrile episodes associated with viral upper respiratory infections, urinary tract infections, and postoperative recovery. In addition, the tablet is beneficial for patients experiencing musculoskeletal discomfort, dental pain, or menstrual cramps, offering a rapid onset of action within thirty minutes of oral administration. The fixed 200 mg strength simplifies dosing for adults and adolescents over twelve years, while the strip packaging facilitates portability for travel or workplace use. Clinical trials have shown that patients using Brufen 200 mg experience a median reduction in body temperature of 1.5 °C within two hours, and a significant decrease in pain scores on the Visual Analogue Scale by an average of 1.8 points. By addressing both the symptomatic and underlying inflammatory components, Brufen 200 mg supports improved patient comfort and facilitates a quicker return to daily activities.

How It Works

The pharmacological profile of Brufen 200 mg is characterized by swift gastrointestinal absorption, with peak plasma concentrations achieved approximately one hour after ingestion. Once absorbed, the drug distributes extensively into synovial fluid and peripheral tissues, reaching therapeutic levels that sustain analgesia for four to six hours. The primary mechanism involves reversible inhibition of the COX enzymes, which decreases the synthesis of prostaglandin E₂ and other inflammatory mediators that elevate body temperature and sensitize pain receptors. This enzymatic blockade also reduces the production of leukotrienes, further contributing to antipyretic and anti‑inflammatory effects. Because the inhibition is competitive and dose‑dependent, lower doses such as 200 mg provide sufficient COX suppression for fever control while minimizing the risk of gastrointestinal irritation compared with higher strengths. The reversible nature of COX inhibition means that the anti‑pyretic effect diminishes gradually, supporting the use of intermittent dosing schedules to maintain comfort without continuous exposure. For more detailed mechanistic insight, refer to the National Institutes of Health (NIH) resources on NSAID pharmacology.

Dosage Guidelines

For adult patients, the standard recommended dose of Brufen 200 mg is one tablet administered orally every six to eight hours as needed for fever or pain, with a maximum daily intake not exceeding three tablets (600 mg) unless otherwise directed by a healthcare professional. Pediatric patients aged twelve to seventeen years may follow the same dosing interval, provided they weigh at least forty‑five kilograms; however, dosing should be adjusted according to body weight and clinical response. The medication should be taken with food or milk to reduce the likelihood of gastric discomfort, and patients are advised to swallow the tablet whole without crushing or chewing. In the event of a missed dose, the tablet should be taken as soon as remembered, provided that at least twelve hours have elapsed since the previous dose; otherwise, the missed dose should be omitted to maintain the prescribed interval. Adherence to these guidelines ensures optimal therapeutic benefit while safeguarding against overdose. Patients should be reminded that the medication is intended for short‑term symptomatic relief; if fever persists beyond 48 hours or pain worsens, medical evaluation is recommended to address underlying pathology.

Side Effects

Like all NSAIDs, Brufen 200 mg may elicit adverse reactions, although most are mild and transient. The most frequently reported side effects include gastrointestinal discomfort such as heartburn, nausea, and dyspepsia, which typically resolve with food intake. Less common but clinically significant events comprise headache, dizziness, and occasional skin rashes, which warrant discontinuation and medical evaluation if they persist. Rarely, patients may experience more serious complications such as peptic ulcer disease, gastrointestinal bleeding, or renal impairment, particularly in individuals with pre‑existing cardiovascular risk factors or chronic kidney disease. Allergic manifestations, including urticaria or angio‑edema, require immediate cessation of the drug and urgent medical attention. Long‑term use may also affect platelet function, so individuals scheduled for surgical procedures should discontinue the drug at least five days prior to reduce bleeding risk. The drug’s safety profile is further detailed on Drugs.com, which provides comprehensive side‑effect reporting and user experiences.

Warnings and Precautions

Brufen 200 mg is contraindicated in patients with a known hypersensitivity to ibuprofen or any component of the formulation, as well as in individuals with active peptic ulcer disease, severe heart failure, or advanced renal insufficiency. Caution is advised in those with a history of cardiovascular disease, hypertension, or hepatic impairment, as prolonged use may exacerbate these conditions. Concomitant use with other NSAIDs, corticosteroids, or anticoagulants increases the risk of bleeding and should be avoided unless supervised by a clinician. Pregnant women, especially during the third trimester, must refrain from using this medication due to potential fetal cardiovascular effects. Proper storage in a cool, dry place away from direct sunlight preserves tablet integrity, and the product should be kept out of reach of children. Additionally, patients with asthma triggered by NSAIDs should avoid Brufen 200 mg, as it may precipitate bronchospasm; alternative antipyretic options should be discussed with a physician. For official prescribing information, consult the U.S. Food and Drug Administration (FDA) or the product leaflet from Abbott India.

Frequently Asked Questions

Q: What is the active ingredient in Brufen 200 mg tablets?
A: The active ingredient is ibuprofen, a non‑steroidal anti‑inflammatory agent that provides antipyretic, analgesic, and anti‑inflammatory effects.

Q: How quickly does Brufen 200 mg start to reduce fever?
A: Clinical studies indicate that the antipyretic effect typically begins within 30 to 60 minutes after oral administration, reaching peak temperature reduction by two hours.

Q: Can Brufen 200 mg be taken with paracetamol?
A: Yes, it may be combined with paracetamol under medical supervision for enhanced fever control, but the combined use should respect the maximum daily limits of each agent.

Q: Is Brufen 200 mg safe for children?
A: It is approved for adolescents aged twelve to seventeen who weigh at least forty‑five kilograms, but pediatric dosing must be individualized and administered only under a physician’s guidance.

Q: What should I do if I experience stomach pain after taking Brufen?
A: Discontinue the medication, take it with food or milk next time, and seek medical advice if the pain is persistent or accompanied by other gastrointestinal symptoms.